Journal article
Heterozygous expression of the oncogenic Pik3caH1047R mutation during murine development results in fatal embryonic and extraembryonic defects
LM Hare, Q Schwarz, S Wiszniak, R Gurung, KG Montgomery, CA Mitchell, WA Phillips
Developmental Biology | ACADEMIC PRESS INC ELSEVIER SCIENCE | Published : 2015
Abstract
The phosphoinositide 3-kinase (PI3K)/AKT signalling pathway regulates many cellular functions including proliferation, migration, survival and protein synthesis. Somatic mutations in PIK3CA, the gene encoding the p110α catalytic subunit of PI3K enzyme, are commonly associated with many human cancers as well as recently being implicated in human overgrowth syndromes. However, it is not clear if such mutations can be inherited through the germline. We have used a novel mouse model with Cre recombinase (Cre)-conditional knock-in of the common H1047R mutation into the endogenous Pik3ca gene. Heterozygous expression of the Pik3caH1047R mutation in the developing mouse embryo resulted in failed 't..
View full abstractRelated Projects (2)
Grants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
The authors would like to thank Jan Williamson and our animal facility staff for their technical assistance and Professor Masashi Yanagisawa, University of Texas Southwestern Medical Center, for kindly providing the Tie2Cre mice. This work was funded, in part, by Grants 628620 and 628621 from the National Health and Medical Research Council (NHMRC) of Australia to WAP. LMH was the recipient of an Australian Postgraduate Award.